17th Multidisciplinary Management of Cancers:A CASE-BASED APPROACHSPONSORED BY the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center.

2017 TUMOR BOARD CASES AND PANELS

March 17-19, 2017Silverado Resort & SpaNapa, California

• Breast Cancer• Developmental Therapeutics• End of Life Care• Gastrointestinal Cancers

• Genitourinary Cancers• Gynecologic Cancers• Head and Neck Cancers• Hematologic Malignancies

• Lymphoma• Sarcoma• Thoracic Cancer

CONFERENCE INFORMATION

Multidisciplinary Management of Cancers:A Case-based Approach

CONFERENCE DESCRIPTIONThis conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, gastrointestinal, genitourinary, gynecologic, head and neck, hematologic malignancies, lymphoma, sarcoma, and thoracic cancers as well as developmental therapeutics and end-of-life care. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation and medical oncologists from Stanford, UC Davis, UC San Francisco, and the practice community.

TARGET AUDIENCEThis course is designed for physicians specializing in medical, surgical, and radiation oncology as well as nurses, pharmacists, and other allied health professionals who work with cancer patients.

STATEMENT OF EDUCATIONAL NEED Because the standard of care in oncology changes rapidly with new discoveries, there is a need for frequent updates of practical relevance for the practicing oncologist. This conference will emphasize standard of care issues for various cancers including diagnostic and therapeutic decision-making and optimal approaches to supportive and palliative care. The faculty at the Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center put a premium on optimal multidisciplinary modeling treatment and education of the practicing oncologist to ensure they are up to date. The American Society for Clinical Oncology recommends this multidisciplinary meeting format. This symposium and its faculty specifically address the clinical guidelines set forth by the National Comprehensive Cancer Network.

LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Develop multidisciplinary treatment strategies based on

national clinical practice guidelines in oncology in order to improve quality of care for cancer patients.

2. Counsel patients on end-of-life care. 3. Discuss relevant clinical trials with cancer patients and

refer appropriately.

CONFERENCE FORMATThe format of the conference is oriented around tumor board

cases. We will use an interactive group response system with an electronic keypad for each participant during the case discussions. We encourage you to submit cases for discussion.

CALL FOR CASE SUBMISSIONSRegistrants are encouraged to submit a case or cases for the panels to discuss. Deadline for case submissions is Friday, December 30, 2016. The organizing committee and panel chairs will select cases. Please visit the course website for the case submission form: www.multicancers.org.

ACCREDITATION AND CREDIT DESIGNATIONPhysicians. The University of California, San Francisco, Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of California, San Francisco, Office of Continuing Medical Education designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses. The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements, as long as the course is certified for AMA PRA Category 1 Credits™ (rn.ca.gov). Nurses will receive a Certificate of Attendance following this activity that may be used for license renewal.

Physician Assistants. AAPA accepts category 1 credit from AOACCME, Prescribed credit from AMA category 1 credit forthe PRA for organizations accredited by the ACCME.

FACULTY DISCLOSURE The University of California, San Francisco, Office of Continuing Medical Education adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships will be made prior to the activity.

PLANNING COMMITTEEA. Dimitrios Colevas, MD (Conference Co-Director)David Gandara, MD (Conference Co-Director)Margaret Tempero, MD (Conference Co-Director) Courtney Flookes and Jose Luis Gonzalez (Conference Planners)

Tell a colleague! To register online go to: www.multicancers.org 2

MESSAGE SCHEDULEfrom the Co-Directors

Dear Colleagues,

It is a pleasure for us to invite you to the 17th

Multidisciplinary Management of Cancers meeting to

be held March 17-19, 2017. The 2017 program represents

a collaborative effort of expert clinicians from the

Stanford Cancer Institute, University of California,

Davis, University of California, San Francisco, and the

Association of Northern California Oncologists.

Based on the recurrent enthusiasm for a case oriented

approach we once again will be tackling some of

the toughest cases, heavily relying upon audience

participation and feedback. Community oncologists

will be represented on the panels as well. With that

in mind, we remind you that we look forward to your

submission of real cases to discuss. Using our online

case submission form, please submit cases for us by the

end of December 2016. We will select cases from among

those submitted for presentation.

Our primary goal of this meeting, as always, is to

provide learners with the latest developments in the

multidisciplinary management of cancers.

Space is limited so register early. We look forward to

your participation at this meeting.

Sincerely,

FRIDAY, MARCH 17, 20177:30–8:30 Registration and Continental Breakfast

8:30–8:45 Welcome and Opening Remarks

8:45–10:45 Breast Cancer Tumor Board Cases (2 hrs) Helen K. Chew, MD – CHAIR

Professor of Medicine, The Joe Sullivan Hematology and Oncology Program Director, UC Davis

Richard J. Bold, MD, UC Davis

Kathleen Horst, MD, Stanford

Leslie Oesterich, MD, UC Davis

Hope S. Rugo, MD, UC San Francisco

George W. Sledge, Jr., MD, Stanford

Melinda Telli, MD, Stanford

Amanda Wheeler, MD, Stanford

10:45–11:00 Break

11:00–12:00 Head and Neck Cancers Tumor Board Cases (1 hr)

Sue Yom, MD, PhD – CHAIR Associate Professor, Department of Radiation Oncology, UC San Francisco

Alain Algazi, MD, UC San Francisco

Beth M. Beadle, MD, PhD, Stanford

Christopher Chapman, MD, UC San Francisco

A. Dimitrios Colevas, MD, Stanford

Patrick Ha, MD, UC San Francisco

Chris Holsinger, MD, Stanford

Jed Katzel, MD, The Permanente Medical Group

Shyam Rao, MD, PhD, UC Davis

Jonathan Riess, MD, MS, UC Davis

12:00–1:00 Lunch

1:00–3:00 Hematologic Malignancies Tumor Board Cases (2 hrs)

Jason Gotlib, MD, MS – CHAIRProfessor of Medicine, Stanford

Mehrdad Abedi, MD, UC Davis

Lloyd Damon, MD, UC San Francisco

Brian A. Jonas, MD, PhD, UC Davis

Greg Kaufman, MD, Stanford

Michaela Liedtke, MD, Stanford

Bruno Medeiros, MD, Stanford

Neil Shah, MD, PhD, UC San Francisco

Ann Von Gehr, MD, The Permanente Medical Group

3:00–3:15 Break

3:15–5:15 Thoracic Cancer Tumor Board Cases (2 hrs)

Joel Neal, MD – CHAIR Assistant Professor of Medicine (Oncology), Stanford

Deepti Behl, MD, Sutter Sacramento

Colin Blakely, MD, PhD, UC San Francisco

Megan Daly, MD, UC Davis

Elizabeth David, MD, UC Davis

David Gandara, MD, UC Davis

Matthew A. Gubens, MD, MS, UC San Francisco

Billy W. Loo, Jr., MD, PhD, Stanford

Michael Mancuso, MD, Stanford

Joseph B. Shrager, MD, Stanford

3

A. Dimitrios Colevas, MD Conference Co-Director Professor of Medicine (Oncology)

and by courtesy, Otolaryngology, Head and Neck Surgery,

Stanford University School of Medicine

David Gandara, MD Conference Co-Director Thoracic Oncology Program, UC Davis Health System;

Professor, UC Davis Medical School;

Senior Advisor to Director, UC Davis Comprehensive

Cancer Center

Margaret Tempero, MD Conference Co-Director Director, UCSF Pancreas Center;

Leader, Pancreas Cancer Program,

Professor of Medicine, Division of Hematology and

Oncology, UC San Francisco

4

SCHEDULE

FRIDAY, MARCH 17, 2017 – CONTINUED5:15 Adjourn

6:00–7:30 Welcome Reception

SATURDAY, MARCH 18, 20177:00–7:45 Registration, Continental Breakfast, & Displays

7:45–8:00 Welcome and Opening Remarks

8:00–9:30 Lymphoma Tumor Board Cases (1.5 hrs)

Joseph Tuscano, MD – CHAIR Professor of Medicine, UC Davis

Charalambos (Babis) Andreadis, MD, UC San Francisco

Richard Hoppe, MD, Stanford

Lawrence Kaplan, MD, UC San Francisco

Kasra Karamlou, MD, Diablo Valley Hematology Oncology

Rajeev Krishnan, MD, UC Davis

Ronald Levy, MD, Stanford

9:30–9:45 Break

9:45–11:15 End of Life Care Tumor Board Cases (1.5 hrs)

Kavitha Ramchandran, MD– CHAIR Clinical Assistant Professor; Medical Director, Palliative Medicine and PathWell, Stanford

John Hausdorff, MD, Pacific Cancer Care

David Magnus, PhD, Stanford

Daniel Mirda, MD, Annadel Medical Group

Michael Rabow, MD, UC San Francisco

Piyush Srivastava, MD, The Permanente Medical Group

Diane Tseng, MD, Stanford

11:15–12:15 Lunch

12:15–1:45 Genitourinary Cancers Tumor Board Cases (1.5 hrs)

Charles Ryan, MD – CHAIR Professor of Clinical Medicine and Urology; Thomas Perkins Distinguished Professor in Cancer Research, UC San Francisco

Archana Anantharaman, MD, UC San Francisco

Mark K. Buyyounouski, MD, MS, Stanford

Andrea Harzstark, MD, The Permanente Medical Group

Primo N. Lara, Jr., MD, UC Davis

Chong-Xian Pan, MD, PhD, UC Davis

Mack Roach III, MD, UC San Francisco

Eila Skinner, MD, Stanford

Eric Small, MD, UC San Francisco

Sandy Srinivas, MD, Stanford

1:45–2:00 Break

2:00–3:30 Gynecologic Cancers Tumor Board Cases (1.5 hrs)

Oliver Dorigo, MD, PhD – CHAIR Director and Associate Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford

Lee-may Chen, MD, UC San Francisco

Gary Leiserowitz, MD, MS, UC Davis

Jyoti Mayadev, MD, UC Davis

Jennifer Leah McNally MD, Stanford

Bethan Powell, MD, The Permanente Medical Group

Karen Smith-McCune, MD, PhD, UC San Francisco

Betty Suh-Burgmann, MD, The Permanente

Medical Group

Stefanie Ueda, MD, UC San Francisco

3:30 Adjourn

SUNDAY, MARCH 19, 20177:00–7:45 Registration, Continental Breakfast, & Displays

7:45–8:00 Welcome and Opening Remarks

8:00–9:30 Gastrointestinal Cancers Tumor Board Cases (1.5 hrs) Alan Venook, MD – CHAIR

The Madden Family Distinguished Professor of Medical Oncology and Translational Research, UC San Francisco

Emily Bergsland, MD, UC San Francisco

Carlos Corvera, MD, UC San Francisco

Mary Feng, MD, UC San Francisco

George A. Fisher, MD, PhD, Stanford

Edward Kim, MD, PhD, UC Davis

Zach Koontz, MD, Pacific Cancer Care

Pamela Kunz, MD, Stanford

Yan Li, MD, The Permanente Medical Group

Margaret Tempero, MD, UC San Francisco

Carling Ursem, MD, UC San Francisco

Brendan C. Visser, MD, Stanford

9:30–9:45 Break

9:45–11:15 Sarcoma Tumor Board Cases (1.5 hrs)Robert Canter, MD – CHAIR Associate Professor of Surgery, Division of Surgical Oncology, UC Davis

Raffi Avedian, MD, Stanford

Kristen Ganjoo, MD, Stanford

Thierry Jahan, MD, UC San Francisco

Lynn Million, MD, Stanford

Ross Okimoto, MD, UC San Francisco

Ming-Gui Pan, MD, The Permanente Medical Group

Rosanna Wustrack, MD, UC San Francisco

11:15–11:30 Break

11:30–1:00 Developmental Therapeutics (1.5 hrs)Pamela Munster, MD – CHAIR Professor of Medicine; Director, Early Phase Clinical Trials; Co-Director, Center for BRCA Research, UC San Francisco

Rahul Aggarwal, MD, UC San Francisco

Mallika Dhawan, MD, UC San Francisco

Karen Kelly, MD, UC Davis

Shivaani Kummar, MD, Stanford

Tianhong (Tina) Li, MD, PhD, UC Davis

Arta Monjazeb, MD, PhD, UC Davis

Branimir I. (Brandy) Sikic, MD, Stanford

1:00 Adjourn

Panelists have been invited; program subject to change. Opportunities for Q&A will be provided during each panel.

5

REGISTER

REGISTRATIONRegistration includes course materials, continental breakfast each day, lunch on Friday and Saturday, and a hosted welcome reception on Friday evening.

ANCO MD Members: $475

Other MD, PhD, PharmD: $500 Early Bird – Registration before 2/1/17

$550 Registration 2/1/17–2/28/17

$600 Late Registration 3/1/17–3/10/17

Nurses/Allied Health: $350 Early Bird – Registration before 2/1/17

$400 Registration 2/1/17–2/28/17

$450 Late Registration 3/1/17–3/10/17

Trainees and students: $100

Industry Representatives: $750

To register, please go online to www.multicancers.org

ACCEPTED METHODS OF PAYMENTCredit Card (Visa, Mastercard, or American Express) – Register online at www.multicancers.org. If you prefer to pay by phone or check, please contact the University of California, San Francisco, Office of Continuing Medical Education at 415-476-5808 for assistance (note that your registration is not confirmed until payment is received).

Online registration closes at end of business day on 3/10/17. Registration will open onsite the day of the conference if space is available. A $75 onsite registration fee will be added to all onsite registrations. Course materials are not guaranteed for onsite registrants.

CANCELLATION POLICYAll cancellations must be made in writing and sent to University of California, San Francisco, Office of Continuing Medical Education, 3333 California Street, Suite 450, San Francisco, CA 94118, or registration@ocme.ucsf.edu. Registration fee, less a $50 administrative charge is refundable if written cancellation is received prior to March 3, 2017. No refunds will be given for cancellations received after this date or for conference non-attendance. We reserve the right to cancel or postpone any activity if necessary. In such case, full refund of registration fee will be given. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

CONTACT INFORMATIONFor questions concerning registration or meeting logistics, please contact:

UCSF Office of CME3333 California Street, Suite 450San Francisco, CA 94118415-476-5808 • registration@ocme.ucsf.edu

UCSF Office of CME is fully ADA compliant. If you have needs that require special accommodations, including dietary concerns, please contact registration@ocme.ucsf.edu before March 3, 2017.

0569University of California,San FranciscoOffice of ContinuingMedical EducationUCSF Box 0742San Francisco, CA94143-0742

Conference Information continued...

CONFERENCE LOCATIONSilverado Resort & Spa

1600 Atlas Peak Road • Napa, California 94558 tel: 707.257.0200

For driving directions and maps, please visit silveradoresort.com/directions

SILVERADO RESORT CONTACT INFORMATION

Silverado Reservations: 1.800.532.0500

Spa Reservations: (707)-257-5555 • Golf Reservations: (707) 257-5460

ACCOMMODATIONSA block of rooms has been reserved at a reduced rate at the Silverado Resort and Spa. Resort guestrooms are available at the rate of $175; junior suites are available at the rate of $215; and, one-bedroom suites are available at the rate of $250 plus tax and resort fees per night (single or double occupancy).

Room reservations should be made directly with the Silverado Resort and Spa and as early as possible. The ‘Multidisciplinary Management of Cancers’ room block rates will only be available until Tuesday, February 14, 2017. After this date, reservations will be accepted on a space available basis and at regular resort rates.

Please go to https://resweb.passkey.com/go/Multicancers to make your hotel reservations or call 1.800.532.0500.

VISITING NAPA & RESTAURANTSThe Napa Valley is world renown as being a premier destination to visit for wineries, golf, arts and culture as well as its famous culinary scene. To discover things to do and restaurants to visit in the Valley, please go to www.visitnapavalley.com.